C Vallbracht
Overview
Explore the profile of C Vallbracht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Degenhardt R, Unverdorben S, Edel K, Brusis O, Vallbracht C, Unverdorben M
Sportverletz Sportschaden
. 2007 Jun;
21(2):79-82.
PMID: 17559021
Introduction: Rehabilitation in ambulatory heart groups has become well established in comprehensive cardiac care. The prevention of injuries is critical to the safety and efficiency of the program. Methods: Questionnaires...
2.
Unverdorben M, Spielberger A, Schywalsky M, Labahn D, Hartwig S, Schneider M, et al.
Cardiovasc Intervent Radiol
. 2002 Mar;
25(2):127-32.
PMID: 11901431
Purpose: The lifelong persistence of foreign bodies within the arteries may contribute to restenosis. Thus, biodegradable devices might decrease recurrence rates. Methods: Eleven polyhydroxybutyrate biodegradable stents and 13 tantalum stents...
3.
Unverdorben M, Glaeser P, Degenhardt R, Rippin G, Berthold H, Vallbracht C
J Invasive Cardiol
. 2001 Dec;
13(12):774-81.
PMID: 11731687
Purpose: The trauma induced by balloon angioplasty has an impact on the outcome of coronary interventions, such as stent procedures. However, balloon inflation for PTCA is not yet standardized even...
4.
Unverdorben M, Spielberger A, Schywalsky M, Labahn D, Schneider M, Degenhardt R, et al.
Rofo
. 2001 Oct;
173(9):836-41.
PMID: 11582564
Objectives: Mechanisms of restenosis after coronary stent implantation include marked intimal proliferation as well as vascular tissue protrusion through the meshes. Thus, stent sheathed with membranes may be an alternative...
5.
Unverdorben M, Kolb M, Bauer I, Bauer U, Brune M, Benes K, et al.
Med Sci Sports Exerc
. 2000 Oct;
32(10):1674-8.
PMID: 11039636
Purpose: Sports in cardiovascular patients (CVP) should serve for risk factor management, increase of exercise capacity, and reintegration into daily life. Competition of cardiac patients with healthy sportsmen is often...
6.
Schrader R, Steinbacher S, Burger W, Kadel C, Vallbracht C, Kaltenbach M
J Invasive Cardiol
. 2000 Apr;
11 Suppl B:14B-18B.
PMID: 10745612
Unlabelled: One-hundred patients undergoing routine diagnostic or interventional catheterization were randomly assigned to receive either percutaneously applied collagen (group A; n = 50) or conventional pressure dressing (group B; n...
7.
Werner C, Bloss P, Kiessling D, Patzschke H, Unverdorben M, Vallbracht C
Biomed Tech (Berl)
. 1999 Dec;
44(11):300-7.
PMID: 10608073
In this report, the results of complementary studies of pressure-volume (p-V) measurements on balloon catheters with balloons of low (LC) and high compliance (HC) used for percutaneous transluminal coronary angioplasty...
8.
Unverdorben M, Bauer U, Oster H, Kraska H, Vallbracht C
Eur J Radiol
. 1999 Jul;
29(3):273-5.
PMID: 10399616
Five years after open chest surgery because of three vessel coronary artery disease a patient was referred for progressing dyspnea and recent onset of atrial fibrillation. A retrocardiac mass was...
9.
Vallbracht C, Kadel C, Wagner E, Abt B, Unverdorben M, Kober G, et al.
Z Kardiol
. 1998 Oct;
87 Suppl 3:28-30.
PMID: 9791904
No abstract available.
10.
[Transluminal coronary angioplasty. 20 years follow-up of the first 6 Zurich and Frankfurt patients]
Vallbracht C, Schlumpf M, Achenbach S, Steinbrunn W, Senning O, Satter P, et al.
Z Kardiol
. 1998 Oct;
87 Suppl 3:1-5; discussion 5-7.
PMID: 9791897
No abstract available.